Peter Jones: The industry needed to communicate the progress properly, and not let scaremongering prevail
Animal health companies must find better ways of communicating the benefits of veterinary medicines to the public, says IFAH, the global animal health industry association. 
The use of new medicines to protect animals and consumers, and subsequent consumer expectations were key themes at the TOPRA (the Organisation for Professionals in Regulatory Affairs) annual symposium held in Copenhagen, Denmark, last week.
Dr Peter Jones, chief executive of IFAH, told the conference that the industry had made progress in developing new pharmaceutical and biotechnology products, such as the licensing of GMO (genetically modified organism) vaccines. However, the industry needed to communicate this progress properly, and not let scaremongering prevail, he said.
Recent outbreaks of animal disease, especially zoonotic ones such as avian influenza (AI), have highlighted how medicines for animals can help prevent human cases of the disease. However, they have also shown that the public needs to receive correct information. In the case of AI, Dr Jones stressed that it was primarily a disease of animals, and not man, and that consumers needed to understand this....
Email a friend
Digital RSS Feed
